The principal goal of the Education & Information Transfer Core (Core D) of our Alzheimer's Disease Research Center (ADRC) is to communicate information concerning issues related to aging and age-associated disorders, particularly Alzheimer's disease (AD). Using a variety of information transfer vehicles, our program is designed to reach three groups: the lay public, including members of families of affected individuals and other caregivers; medical/graduate students, clinical investigators, and basic scientists; and physicians, nurses, social workers, and other professionals working in the health care field. Outreach programs are designed to communicate with individuals, families, caregivers, lay persons, and local and regional non-academic associations of health professionals and with minority populations We have initiated a newsletter for families, caregivers, and the lay public, and are making a concerted effort to educate minorities in our region concerning AD. To train young clinicians and scientists, we have continued existing programs and have created a formal Neurobiology of Disease Training Program, which was recently funded by the NIH. This grant will provide stipends to trainees, some of whom will work on ADRC projects. The ADRC sponsors a series of lectures, seminars, opportunities for clinical/laboratory rotations and a Visiting Professor Lectureship. At the local, national, and international levels, ADRC clinicians/scientists participate in a broad range of meetings whose focus ranges from clinical issues (diagnosis, therapeutic trials, etc.), to animal models, to cellular/molecular biology. By facilitating the exchange of information, the activities of the ADRC promote public awareness, aid caregivers, health professionals, and encourage new investigators to enter the field of aging and AD. In summary, Core D helps us to realize several goals: to educate the public concerning AD and related disorders; to disseminate new findings from clinical and basic research to the lay, medial, and scientific communities for these individuals to do clinical and/or basic research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005146-17
Application #
6210908
Study Section
Special Emphasis Panel (ZAG1-PCR-3 (J5))
Project Start
1984-09-28
Project End
2004-03-31
Budget Start
Budget End
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211

Showing the most recent 10 out of 830 publications